Research / Stocks / CCLD CCLD Nasdaq CIK 0001582982
CareCloud, Inc. · Services-Prepackaged Software
COVERAGE / STANDARD
Latest filing 4 · Aug 10, 2026
Research state Latest filing analysis is current
Last SEC check Sep 13, 2026
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT CareCloud, Inc.'s latest supported as-filed period reports revenue of $31.9M , 16.4% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Capex intensity 56th Own-history percentile · N=9
Method Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.65% · OPTIONAL
Operating cash generation 56th Own-history percentile · N=9
Method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 22.19% · OPTIONAL
Revenue growth RAW Current state valid · history insufficient
Method Yoy · gp.fundamentals.revenue
Raw value 16.45% · CORE
Inventory pressure 33th Own-history percentile · N=9
Method Level · gp.fundamentals.inventory_revenue_ratio
Raw value 1.48% · OPTIONAL
Operating margin 22th Own-history percentile · N=9
Method Level · gp.fundamentals.operating_margin
Raw value 5.84% · CORE
R&D intensity 89th Own-history percentile · N=9
Method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 6.88% · OPTIONAL
SBC intensity 22th Own-history percentile · N=9
Method Level · gp.fundamentals.sbc_revenue_ratio
Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Jun 30, 2026 General Corporate
Governance Evidence 4 evidence-backed dimensions Filing Amendments Repeated Auditor Changes Observed Sbc Intensity Observed Insider Activity Observed [email protected] · 6 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Comparable evidence Peer context Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Sbc Intensity
CCLD 0.2
Peer median 10.9
Peer percentile 1th 142 valid peers · 90% coverage · -1.3 robust σ R And D Intensity
CCLD 6.9
Peer median 21.6
Peer percentile 5th 131 valid peers · 83% coverage · -1.2 robust σ Capex Intensity
CCLD 1.6
Peer median 0.9
Peer percentile 63th 124 valid peers · 79% coverage · +0.6 robust σ Growth
CCLD 16.4
Peer median 10.6
Peer percentile 66th 129 valid peers · 82% coverage · +0.4 robust σ Profitability
CCLD 5.8
Peer median -1.8
Peer percentile 65th 148 valid peers · 94% coverage · +0.3 robust σ Cash Generation
CCLD 22.2
Peer median 16.4
Peer percentile 60th 143 valid peers · 91% coverage · +0.3 robust σ Open group breadth → Divergence is context, not positive or negative. INSIDER STATE / 90D Recent disclosed activity
Open-market purchases 0
Sales 0
Distinct buyers 0
Repeat buyer NO Conservative Form 4 classification · not a sentiment label Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0001493152-26-036363 7 governed changes · top 7 shown
01
LOW IMPORTANCE Inventory 0TH HISTORICAL PCTL · N=3
Inventory decreased 9.9% Inventory changed -9.9% from the comparable as-filed period.
Why this ranks here · [email protected] $523,000 → $471,000 Comparable → current
02
HIGH IMPORTANCE Net Income 50TH HISTORICAL PCTL · N=2
Net income decreased 61.3% Net income changed -61.3% from the comparable as-filed period.
Why this ranks here · [email protected] $2.9M → $1.1M Comparable → current
03
HIGH IMPORTANCE Operating Income 33TH HISTORICAL PCTL · N=3
Operating income decreased 37.9% Operating income changed -37.9% from the comparable as-filed period.
Why this ranks here · [email protected] $3.0M → $1.9M Comparable → current
04
HIGH IMPORTANCE Margin 67TH HISTORICAL PCTL · N=3
Operating margin moved 510 bp lower Operating margin changed -510 basis points from the comparable as-filed period.
As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 1.65% +25.0% ↑ Capital expenditure $525,000 +27.4% ↑ Cash & equivalents $6.4M -16.4% ↓ Free-cash-flow proxy $6.5M +104.7% ↑ Interest income -$742,000 -1445.8% ↓ Inventory $471,000 +9.0% ↑ Net income $1.1M +21.7% ↑ Operating cash flow $7.1M +95.9% ↑
ACTIVE TRACE Revenue CCLD · as filed with the SEC · reported-date aware
Capex / revenue Q2 / 2026-06-30 1.65% +25.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q2 / 2026-06-30 $525,000 +27.4% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q3 / 2023-09-30 $6.4M -16.4% sequential point Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q2 / 2026-06-30 $6.5M +104.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Interest income Q2 / 2026-06-30 -$742,000 -1445.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Inventory Q2 / 2026-06-30 $471,000 +9.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q2 / 2026-06-30 $1.1M +21.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q2 / 2026-06-30 $7.1M +95.9% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q2 / 2026-06-30 5.84% +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Research & development Q2 / 2026-06-30 $2.2M -9.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Revenue Q2 / 2026-06-30 $31.9M +2.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Stock-based compensation Q2 / 2026-06-30 $64,000 +0.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
4 Aug 10, 2026 Period Aug 8, 2026 0001493152-26-036951SEC ↗ 4 Aug 10, 2026 Period Aug 8, 2026 0001493152-26-036950SEC ↗ 4 Aug 10, 2026 Period Aug 8, 2026 0001493152-26-036949SEC ↗ 4 Aug 10, 2026 Period Aug 8, 2026 0001493152-26-036948SEC ↗ 10-Q Aug 6, 2026 Period Jun 30, 2026 0001493152-26-036363SEC ↗ 8-K Aug 6, 2026 Period Aug 6, 2026 0001493152-26-036255SEC ↗ 4 Jul 31, 2026 Period Jul 29, 2026 0001493152-26-035714SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗